Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Cho Han Chiang"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c92660ebd96547c28858113d354d5121
Autor:
Chun-Yu Peng, Yu-Cheng Chang, Changlin Gong, Yu Chang, Kuan-Yu Chi, Chieh-Lien Hsiao, Cho-Hung Chiang, Cho-Han Chiang
Publikováno v:
Anesthesiology; Nov2024, Vol. 141 Issue 5, p1009-1012, 4p
Autor:
Cho‐Han Chiang, Yu‐Cheng Chang, Shih‐Syuan Wang, Yuan‐Jen Chen, Xin Ya See, Chun‐Yu Peng, Yuan Ping Hsia, Cho‐Hsien Chiang, Cho‐Hung Chiang, Cheng‐Ming Peng
Publikováno v:
Cancer Medicine. 12:9583-9588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a79aa43248799f05fe90830cad90f028
https://doi.org/10.1002/cam4.5734
https://doi.org/10.1002/cam4.5734
Autor:
Cho-Han Chiang, Sung-Ching Pan, Tyan-Shin Yang, Keisuke Matsuda, Hong Bin Kim, Young Hwa Choi, Satoshi Hori, Jann-Tay Wang, Wang-Huei Sheng, Yee-Chun Chen, Feng-Yee Chang, Shan-Chwen Chang
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 7, Iss 1, Pp 1-12 (2018)
Abstract Background Sustainable systematic interventions are important for infection prevention and control (IPC). Data from surveillance of healthcare-associated infections (HAI) provides feedback for implementation of IPC programs. To address the p
Externí odkaz:
https://doaj.org/article/87c3d66c5938491a9e71a71ba13b387b
Autor:
Cho-Han Chiang, Yuan-Jen Chen, Cho-Hsien Chiang, Cheng-Ying Chen, Yu-Cheng Chang, Shih-Syuan Wang, Xin Ya See, Chuan-Sheng Horng, Chun-Yu Peng, Yuan Ping Hsia, Cheng-Ming Peng, Cho-Hung Chiang
Publikováno v:
Cancer Immunology, Immunotherapy. 72:1951-1956
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c35cb6ba7f58cd97395b7351c4f66c51
https://doi.org/10.1007/s00262-022-03363-6
https://doi.org/10.1007/s00262-022-03363-6
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Kevin Sheng-Kai Ma, Yuan Ping Hsia, Yu-wen Lee, Han-Ru Wu, Cho-Hsien Chiang, Chun-Yu Peng, James Cheng-Chung Wei, Her-Shyong Shiah, Cheng-Ming Peng, Tomas G Neilan
Publikováno v:
Japanese Journal of Clinical Oncology. 52:1389-1398
Objectives Immune checkpoint inhibitors are associated with adverse cardiovascular events. However, there are no data characterizing cardiovascular events among Asians on immune checkpoint inhibitors. We aim to determine the incidence and risk of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16841869f40b8438b22f02c9ae266073
https://doi.org/10.1093/jjco/hyac150
https://doi.org/10.1093/jjco/hyac150
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, Kevin Sheng-Kai Ma, Chun-Yu Peng, Yuan Ping Hsia, Chuan-Sheng Horng, Cheng-Ying Chen, Yu-Cheng Chang, Xin Ya See, Yuan-Jen Chen, Shih-Syuan Wang, Giselle A Suero-Abreu, LR Peterson, Paaladinesh Thavendiranathan, Philippe Armand, Cheng-Ming Peng, Her-Shyong Shiah, Tomas G Neilan
Publikováno v:
Heart
ObjectivesSodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce heart failure (HF) in at-risk patients and may possess antitumour effects. We examined the effect of SGLT2i on HF and mortality among patients with cancer and diabetes.MethodsThis wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad28687ea28a167810df6ddcf36a018
https://europepmc.org/articles/PMC10037540/
https://europepmc.org/articles/PMC10037540/
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, Jing-Huey Chiu, Kevin Sheng-Kai Ma, Brian Shiian Chen, Yu-Ze Luan, Teng-Chieh Cheng, Ching-Lung Hsieh, Cheng-Ming Peng
Publikováno v:
Pancreas. 51:e107-e109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34c292df2807df6537092bc4f406f636
https://doi.org/10.1097/mpa.0000000000002125
https://doi.org/10.1097/mpa.0000000000002125
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 8, Pp 1962-1962 (2020)
Externí odkaz:
https://doaj.org/article/95703c78492146b887c4c2a385975a4b
Autor:
Stefan Blankenberg, Pui-Un Tang, Tomas G. Neilan, Gin Hoong Lee, William F. Peacock, Raphael Twerenbold, Nicolas Buttinger, Michael A. Liu, Christian Mueller, Evangelos Giannitsis, Arash Mokhtari, Wan-Ting Hsu, Martin Than, Michael Amann, Dirk Westermann, Johannes T Neumann, Dan Atar, Chien-Chang Lee, Kenji Inoue, Richard M. Nowak, K.W. Su, Ulf Ekelund, Tonje R. Johannessen, Derek P. Chew, Philipp Bahrmann, Francisco Ojeda, John W. Pickering, Cho-Han Chiang, Kiril M. Stoyanov, Andrew Worster, Christopher DeFilippi, Peter A. Kavsak, Cho-Hung Chiang, Nils A Sörensen, Onlak Ruangsomboon, Kevin Sheng-Kai Ma, Maureen Dooley, Willibald Hochholzer
Publikováno v:
Annals of Internal Medicine. 175:101-113
BACKGROUND The 2020 European Society of Cardiology (ESC) guidelines recommend using the 0/1-hour and 0/2-hour algorithms over the 0/3-hour algorithm as the first and second choices of high-sensitivity cardiac troponin (hs-cTn)-based strategies for tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8743ebcc81b7ec844880d46e99f3dfbc
https://doi.org/10.7326/m21-1499
https://doi.org/10.7326/m21-1499